Identification and antigenic epitope mapping of immunodominant region amino residues 510 to 672 on the spike protein of the severe acute respiratory syndrome coronavirus

DNA and Cell Biology

Volumn 24, Issue 8, 2005, Pages 503-509

  Hua, Rong Hong ^a   Wang, Yun Feng ^a   Bu, Zhi Gao ^a   Zhou, Yan Jun ^a   Ge, Jin Ying ^a   Wang, Xi Jun ^a   Tong, Guang Zhi ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; EPITOPE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; SARS CORONAVIRUS SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DIAGNOSTIC TEST; IMMUNITY; IMMUNIZATION; INSECT CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRION; VIRUS RECOMBINANT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; EPITOPE MAPPING; EPITOPES; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; SARS VIRUS; VIRAL ENVELOPE PROTEINS;

CORONAVIRUS; INSECTA; SARS COV;

EID: 24644443295     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.503     Document Type: Article

References (33)

1. BISHT, H., ROBERTS, A., VOGEL, L., BUKREYEV, A., COLLINS, P.L., MURPHY, B.R., SUBBARAO, K., and MOSS, B. (2004). Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. USA 101, 6641-6646.
2. BOSCH, B.J., VAN DER ZEE, R., DE HAAN, C.A.M., and ROTTIER, P.J.M. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol. 77, 8801-8811.
3. BUCHHOLZ, U.J., BUKREYEV, A., YANG, L., LAMIRANDE, E.W., MURPHY, B.R., SUBBARAO, K., and COLLINS, P.L. (2004). Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. USA 101, 9804-9809.
4. BUKREYEV, A., LAMIRANDE, E.W., BUCHHOLZ, U.J., VOGEL, L.N., ELKINS, W.R., ST CLAIRE, M., MURPHY, B.R., SUBBARAO, K., and COLLINS, P.L. (2004). Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363, 2122-2127.
5. CHOY, W.-Y., LIN, S.-G., CHAN, P.K.-S., TAM, J.S.-L., LO, Y.M.D., CHU, I.M.-T., TSAI, S.-N., ZHONG, M.-Q., FUNG, K.-P., WAYE, M.M.-Y., et al. (2004). Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development. Clin. Chem. 50, 1036-1042.
6. DANIEL, C., ANDERSON, R., BUCHMEIER, M.J., FLEMING, J.O., SPAAN, W.J., WEGE, H., and TALBOT, P.J. (1993). Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure. J. Virol. 67, 1185-1194.
7. DROSTEN, C., GUNTHER, S., PREISER, W., VAN DER WERF, S., BRODT, H.-R., BECKER, S., RABENAU, H., PANNING, M., KOLESNIKOVA, L., FOUCHIER, R.A.M., et al. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967-1976.
8. EICKMANN, M., BECKER, S., KLENK, H.-D., DOERR, H.W., STADLER, K., CENSINI, S., GUIDOTTI, S., MASIGNANI, V., SCARSELLI, M., MORA, M., et al. (2003). Phylogeny of the SARS Coronavirus. Science 302, 1504b-1505.
9. GALLAGHER, T.M. and BUCHMEIER, M.J. (2001). Coronavirus spike proteins in viral entry and pathogenesis. Virology 279, 371-374.
10. GUAN, Y., ZHENG, B.J., HE, Y.Q., LIU, X.L., ZHUANG, Z.X., CHEUNG, C.L., LUO, S.W., LI, P.H., ZHANG, L.J., GUAN, Y.J., et al. (2003). Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276-278.
11. HE, Y., ZHOU, Y., LIU, S., KOU, Z., LI, W., FARZAN, M., and JIANG, S. (2004). Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: Implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 324, 773-781.
12. HUA, R., ZHOU, Y., WANG, Y., HUA, Y., and TONG, G. (2004). Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem. Biophys. Res. Commun. 319, 929-935.
13. KSIAZEK, T.G., ERDMAN, D., GOLDSMITH, C.S., ZAKI, S.R., PERET, T., EMERY, S., TONG, S., URBANI, C., COMER, J.A., LIM, W., et al. (2003). A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966.
14. LI, W., MOORE, M.J., VASILIEVA, N., SUI, J., WONG, S.K., BERNE, M.A., SOMASUNDARAN, M., SULLIVAN, J.L., LUZURIAGA, K., GREENOUGH, T.C., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454.
15. LIU, S., XIAO, G., CHEN, Y., HE, Y., NIU, J., ESCALANTE, C.R., XIONG, H., FARMAR, J., DEBNATH, A.K., TIEN, P., et al. (2004). Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: Implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363, 938-947.
16. MARRA, M.A., JONES, S.J.M., ASTELL, C.R., HOLT, R.A., BROOKS-WILSON, A., BUTTERFIELD, Y.S.N., KHATTRA, J., ASANO, J.K., BARBER, S.A., CHAN, S.Y., et al. (2003). The genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404.
17. MARSHALL, E., and ENSERINK, M. (2004). Medicine. Caution urged on SARS vaccines. Science 303, 944-946.
18. NIE, Y., WANG, G., SHI, X., ZHANG, H., QIU, Y., HE, Z., WANG, W., LIAN, G., YIN, X., DU, L., et al. (2004). Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 190, 1119-1126.
19. PEIRIS, S.S., LAI, S.T., POON, L.L., GUAN, Y., YAM, L.Y., LIM, W., NICHOLLS, J., YEE, W.K., YAN, W.W., CHEUNG, M.T., et al. (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319-1325.
20. QIN, E.D., ZHU, Q.Y., YU, M., FAN, B.C., CHANG, G.H., SI, B.Y., YANG, B.A., PENG, W.M., JANG, T., LIU, B.H., et al. (2003). A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01). Chin. Sci. Bull. 48, 941-948.
21. ROTA, P.A., OBERSTE, M.S., MONROE, S.S., NIX, W.A., CAMPAGNOLI, R., ICENOGLE, J.P., PENARANDA, S., BANKAMP, B., MAHER, K., CHEN, M.-h., et al. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394-1399.
22. SPIGA, O., BERNINI, A., CIUTTI, A., CHIELLINI, S., MENCIASSI, N., FINETTI, F., CAUSARONO, V., ANSELMI, F., PRISCHI, F., and NICCOLAI, N. (2003). Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem. Biophys. Res. Commun. 310, 78-83.
23. SUBBARAO, K., MCAULIFFE, J., VOGEL, L., FAHLE, G., FISCHER, S., TATTI, K., PACKARD, M., SHIEH, W.-J., ZAKI, S., and MURPHY, B. (2004). Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78, 3572-3577.
24. TAKASUKA, N., FUJII, H., TAKAHASHI, Y., KASAI, M., MORIKAWA, S., ITAMURA, S., ISHII, K., SAKAGUCHI, M., OHNISHI, K., OHSHIMA, M., et al. (2004). A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int. Immunol. 16, 1423-1430.
25. TER MEULEN, J., BARKER, A.B., VAN DEN BRINK, E.N., WEVERLING, G.J., MARTINA, B.E., HAAGMANS, B.L., KUIKEN, T., DE KRUIF, J., PREISER, W., SPAAN, W., et al. (2004). Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363, 2139-2141.
26. TRIPET, B., HOWARD, M.W., JOBLING, M., HOLMES, R.K., HOLMES, K.V., and HODGES, R.S. (2004). Structural characterization of the SARS-coronavirus spike S fusion protein core. J. Biol. Chem. 279, 20836-20849.
27. WEINGARTL, H., CZUB, M., CZUB, S., NEUFELD, J., MARSZAL, P., GREN, J., SMITH, G., JONES, S., PROULX, R., DESCHAMBAULT, Y., et al. (2004). Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J. Virol. 78, 12672-12676.
28. WONG, S.K., LI, W., MOORE, M.J., CHOE, H., and FARZAN, M. (2004). A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279, 3197-3201.
29. XIONG, S., WANG, Y.F., ZHANG, M.Y., LIU, X.J., ZHANG, C.H., LIU, S.S., QIAN, C.W., LI, J.X., LU, J.H., WAN, Z.Y., et al. (2004). Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol. Lett. 95, 139-143.
30. YANG, Z.Y., KONG, W.P., HUANG, Y., ROBERTS, A., MURPHY, B.R., SUBBARAO, K., and NABEL, G.J. (2004). A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428, 561-564.
31. ZHANG, H., WANG, G., LI, J., NIE, Y., SHI, X., LIAN, G., WANG, W., YIN, X., ZHAO, Y., QU, X., et al. (2004). Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J. Virol. 78, 6938-6945.
32. ZHENG, B.J., WONG, K.H., ZHOU, J., WONG, K.L., YOUNG, B.W., LU, L.W., and LEE, S.S. (2004b). SARS-related virus predating SARS outbreak, Hong Kong. Emerg. Infect. Dis. 10, 176-178.
33. ZHOU, T., WANG, H., LUO, D., ROWE, T., WANG, Z., HOGAN, R.J., QIU, S., BUNZEL, RJ., HUANG, G., MISHRA, V., et al. (2004). An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies. J. Virol. 78, 7217-7226.